All News TetraLogic Pharmaceuticals Corporation

Equities

TLOG

US88165U1097

Market Closed - OTC Markets Other stock markets 11:53:16 28/05/2024 pm IST			5-day change	1st Jan Change
0.000001 ^USD	-.--%		-.--%	-99.00%

2020	Medivir AB Renegotiates its agreement with TetraLogic Pharmaceuticals Corporation	CI
2017	TetraLogic Pharmaceuticals Corporation Appoints Alexandre Zyngier to Board of Directors and Management	CI

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

MEDIVIR : YEAR-END REPORT JANUARY - DECEMBER 2020	26/21/26	AQ
Medivir : strengthens its business development possibilities through a renegotiated agreement with TetraLogic regarding birinapant	11/20/11	AQ
Medivir AB Renegotiates its agreement with TetraLogic Pharmaceuticals Corporation	11/20/11	CI
TetraLogic Pharmaceuticals Corporation Appoints Alexandre Zyngier to Board of Directors and Management	19/17/19	CI
Tetralogic Pharmaceuticals Corporation Announces Management Resignations	29/16/29	CI
Medivir AB (OM:MVIR B) completed the acquisition of substantially all the assets of TetraLogic Pharmaceuticals Corporation.	29/16/29	CI
TetraLogic Pharmaceuticals Corporation(OTCPK:TLOG) dropped from S&P TMI Index	07/16/07	CI
TetraLogic Pharmaceuticals Corporation(OTCPK:TLOG) dropped from NASDAQ Composite Index	03/16/03	CI
Medivir AB (OM:MVIR B) entered into a definitive asset purchase agreement to acquire substantially all the assets of TetraLogic Pharmaceuticals Corporation for approximately $170 million.	02/16/02	CI
TetraLogic Pharmaceuticals Corporation Announces Resignation of Douglas Reed as M. D, Effective July 21, 2016	23/16/23	CI
TetraLogic Pharmaceuticals Corporation Announces Executive Changes	08/16/08	CI
TetraLogic Pharmaceuticals Corporation(NasdaqGM:TLOG) dropped from CRSP US Total Market Index	21/16/21	CI
TetraLogic Pharmaceuticals Corporation Auditor Raises 'Going Concern' Doubt	16/16/16	CI
TetraLogic Pharmaceuticals Corporation Announces Resignation of Douglas E. Onsi as Member of Board of Directors, Effective February 5, 2016	03/16/03	CI
TetraLogic Pharmaceuticals Corporation Announces Management Terminations; Authorizes the Implementation of a 19 Person Reduction in Staff	22/16/22	CI
TetraLogic Pharmaceuticals Corporation Announces Results of the Interim Analyses of Two Clinical Studies	07/16/07	CI
TetraLogic Pharmaceuticals Corporation Announces Resignation of Michael Steinmetz from the Board of Directors, Effective December 15, 2015	09/15/09	CI
TetraLogic Pharmaceuticals Corporation Announces Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2015; Provides Update on SHAPE Alopecia Areata Program	05/15/05	CI
TetraLogic Pharmaceuticals Corporation Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2015	06/15/06	CI
Certain shares of TetraLogic Pharmaceuticals Corporation's Common Stock are subject to a Lock-Up Agreement Ending on 30-JUL-2015.	30/15/30	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News TetraLogic Pharmaceuticals Corporation

Equities

TLOG

US88165U1097

All News

Filters